Wegovy vs. Zepbound | GLP-1 Clinics Nearby

Wegovy ingredient

Semaglutide

Zepbound ingredient

Tirzepatide

Both require

A prescription

At a glance

Wegovy vs. Zepbound at product level

Brand-level comparison is more useful than comparing two unspecified online offers.

Swipe horizontally to compare →

Wegovy vs. Zepbound at product level. Brand-level comparison is more useful than comparing two unspecified online offers.
Product detail	Wegovy	Zepbound
Active ingredient	Semaglutide	Tirzepatide
Receptor action	GLP-1	GIP and GLP-1
Regulatory status	FDA-approved prescription product	FDA-approved prescription product
Program details to compare	Coverage, pharmacy, follow-up, and continuing cost	Coverage, pharmacy, follow-up, and continuing cost

Table source:FDA product prescribing information

Wegovy and Zepbound are brands, not category labels

Wegovy is a semaglutide product and Zepbound is a tirzepatide product. Both have FDA-approved weight-management uses for eligible patients, but their mechanisms, labels, warnings, instructions, and supporting studies are not identical.

Comparing these products is more precise than comparing an unspecified “semaglutide” or “tirzepatide” offer because it establishes which FDA-approved product is actually under discussion.

The useful comparison has five columns

Start with medical fit, then compare the exact product, your likely access path, the care program, and ongoing cost. A provider should be able to explain each column without turning the answer into a sales pitch.

Medical history, warnings, contraindications, and current medicines
Current product label and prescribed formulation
Insurance coverage, cash price, supply, and pharmacy pathway
Follow-up access, monitoring, and symptom response
Total continuing cost after promotions and dose changes

Why a single efficacy number is not enough

Study results are usually population averages produced under a specific trial design. They do not tell you which product will be tolerated, covered, available, or appropriate for one person.

Ask the prescriber how the evidence applies to your situation and what would cause the plan to continue, change, or stop. That conversation is more useful than choosing from an unsourced ranking graphic.

Do not let a compounded offer borrow a brand name

Some advertisements place brand names beside compounded medication in a way that can blur the difference. Compounded products are not FDA-approved generic versions of Wegovy or Zepbound.

Confirm the label on the product you would receive, the dispensing pharmacy, and whether the price includes a brand-name prescription, a clinical membership, or a compounded preparation.

Check the current FDA label for the product prescribed. This page intentionally does not reproduce a dosing schedule.

Common questions

Answers to clarify the comparison

Are Wegovy and Zepbound both GLP-1 medications?

Wegovy is a GLP-1 receptor agonist. Zepbound activates both GIP and GLP-1 receptors and is commonly compared within the same weight-care category.

Is Zepbound the same as Mounjaro?

Both contain tirzepatide, but they are separate products with different FDA-approved indications and labeling.

Is Wegovy the same as Ozempic?

Both contain semaglutide, but they are separate products with different FDA-approved indications and labeling.

Primary sources

Read the official material behind this page

Health information is educational and does not diagnose, determine eligibility, or replace product labeling and care from a qualified professional.